Eldav Investments Ltd., founded by Mr. Rony Sternbach in 2007, is a public investment company, traded on the Tel Aviv Stock Exchange.
Eldav's investments strategy is focused on public and private companies with significant appreciation potential. Investments are conduct through shares, loans or bonds aimed at enhancing return on capital and value creation to shareholders.
Eldav's investment strategy is focused on companies with significant appreciation potential, in the industrial, services, finance and commercial sectors. Eldav focuses on companies with long operating history, primarily in traditional industries and with accordance with the experience and relative advantage of Eldav's team.
Eldav seeks to influence and support its investments, aimed at establishing their market position and enhance growth. Such support includes optimizing capital resources, establishing growth strategy, business development, as well as involvement in capital raising, acquisitions and divestitures, all with close cooperation with portfolio companies' management.
Eldav's investments decisions are based on several factors, and in relation to the industry in which the target companies operate, including:
Solid business model and leading | market position | Positive cash flow |
Experiences management with equity | based incentives | Product or service | with export potential | Ability to influence through significant ownership interest | Capital structure.
Eldav seeks to leverage its investment experience, industry knowledge and business network to assist portfolio companies in achieving growth, improving profitability and creating value, including:
Setting a business strategy | Growth enhancement through mergers & acquisitions, both locally and abroad | Global expansion and export | Implement incentive- based compensation to managers | Supporting business development activities | Optimizing capital and tax structure.
Mr. Sternbach brings extensive experience in mergers, acquisition, investments and strategic advisory. Prior to establishing Eldav, Mr. Sternbach was a Founding-Partner of IEL Israel Equity, an Israeli private equity firm. During his tenure at IEL, Mr. Sternbach led the purchasing of leading Israeli companies.
Prior to that, Mr. Sternbach was a Senior Advisor at the Mergers and Acquisitions Groups of Deutsche Bank and Bear Stearns in New York. He advised, primarily, large cap clients, in the defense, aerospace and technology sectors, as well as private equity / LBO funds. In this capacity he advised on transactions valued at over $50B. Prior to its acquisition by Deutsche Bank, Mr. Sternbach was a member of the M&A Group of Bankers Trust / Wolfensohn in New York.
Mr. Sternbach, a CPA, holds an MBA degree, with Distinction, from the Wharton Business School, a degree in Real Estate Management and Appraisal, and a BA in Accounting and Economics from Tel Aviv University.
Prior to his position as Eldav's CEO, Mr. Diament held a senior position at the Business Advisory Services Department of Ernst & Young Israel, The leading accounting firm of Israel.
Mr. Diament specialized in financial analysis, carrying out due-diligence, market researches, budgets and other financial activities.
Mr. Diament, a CPA, holds an MBA degree in Financial Management, from Tel Aviv Universuty, as well as a BA in accounting and economy from Tel Aviv University.
Prior to his position in Eldav, Mr. Melcer held a senior position at BDO Ziv Haft consulting group. While working at BDO, Mr. Melcer specialized in financial analysis and companies valuations in all types of industries, carrying out reviews of local and global markets, accounting advisories, valuation of options and other financial instruments, business plans, fairness opinions, budgets and other financial activities.
Prior to that, Mr. Melcer was held a position in PWC Israel. During which, Mr. Melcer was part of a various IFRS reporting companies audit team.
Mr. Melcer, a CPA, holds an MBA degree in Financial Management, from Tel Aviv Universuty, as well as a BA in accounting and economy from Tel Aviv University.
Launched in 2020 in London, Blue Shield Capital is a fast-growing property lending firm committed to simplifying bridge lending. Led by highly-experienced finance professionals and real estate developers, Blue Shield strives to provide highly flexible financing solutions for property owners and investors in an extremely efficient and transparent manner.
M.L.R.N Projects and Trade Ltd. is a private company founded in 2008. The company is engaged in the provision of credit solutions for small and medium size businesses, focusing on the growing Israeli-Arab commercial sector. The Company's credit offerings include: funding receivables backed by deferred notes, ABL finance and real estate finance.
It is considered a market leader in the Israeli-Arab sector and has accumulated extensive goodwill by virtue of its professionalism and the know-how which it has acquired over the years. The added value of the Company is its deep understanding of the Israeli- Arab culture in general and the Israeli-Arab business culture in particular.
Its current credit portfolio amounts to over NIS 300 million, diversified over 1,700 debtors and has average maturity of less than 90 days.
Since inception, the Company underwrote over NIS 8 billion.
Founded in 1987, Comsec is Israel's leading provider of cyber security services as well as a distributor of IT security products. Comsec has a wide range of clients, including, banks, telecommunication companies, insurance companies, public and government agencies and high-tech companies.
Through its subsidiaries, in the UK and the Netherlands, Comsec operates in western Europe, using the knowledge and methodology developed during its many years of experience.
Comsec is also engaged in the distribution and marketing of IT security products, in Israel, representing various hardware and softwares developers.
Comsec was publicly traded on the Tel-Aviv Stock Exchange during 2000-09. In September 2014, Eldav acquired full ownership of Comsec for a total consideration of NIS 76M. Eldav sold its its interest in November 2021 for a profit of NIS 40 Million.
Poalim I.B.I is a leading Iocal investment banking company. It is engaged, primarily, in raising funds from institutional investors in the capital market and underwriting offerings of private and public companies, as well as related capital markets services.
Poalim I.B.I has proven its unique ability to conduct successful offerings in the changing environment of Israel's capital market - from private offerings of varying scope to some of the largest offerings in the local market. As a result, it has been positioned among the leading underwriters in Israel's.
Founded in 1958, Medtechnica (TASE:MEDI) is Israel's leading distributor and service provider of medical and scientific equipment. The Company is traded on the Tel-Aviv Stock Exchange since 1988.
Exclusively representing over 100 leading American, European and Japanese manufactures, Medtechnica markets its products to Israel's HMOs, hospitals, laboratories, clinics and private practices.
Medtechnica provides its customers with a life-cycle support, service and maintenance on a 24-hour basis. Furthermore, it offers a variety of financing solutions to its customers, thereby enabling them to meet budget and financial requirements.
Medtechnica is also engaged in the development and manufacture of medical equipment, mainly through its venture arm Medtechnica Hi-tech, which invests in the medical equipment. Medtechnica utilizes its experience, know-how and contacts in the medical field in Israel and worldwide to promote its portfolio companies.
Eldav acquired a controlling interest in Medtechnica in January 2008 for NIS 117 millions. Following an improvement process, Eldav sold its interest in January 2011 for a profit of NIS 104 Million, represents an IRR of 47%.
Founded in 1981, Trendline information and communication services Ltd. (Kav-Manhe Group) is an Israel-based, business data and information provider. It is engaged, directly and through its subsidiaries, in the supply of various financial data and business related information and analysis through software systems for Internet applications.
Trndline offers real-time and historical financial information to institutions, professional investors and private users. In addition, it offers other information services including legal, taxation and land registration. The Company operates Bizportal.co.il, a leading local financial website with a variety of application and services directed primarily to the local financial community.
In March 2010, Eldav acquired 25% of Trenline shares for NIS 36 millions, which was sold in two tranches in March 2012
Trendline is traded on the Tel-Aviv Stock Exchange since 1991 (TASE:TREN).
Flight Medical is engaged in the development, marketing and distribution of ventilation equipment.
Flight Medical's revolutionary HT-50 and Flight-60 ventilators are world-leading integral, small footprint, lightweight, transportable, low power consumption devices, chiefly used in intensive care medicine, home care and emergency medicine.
Flight achieved an installed base of over 15,000 units, primarily in the US.
The Company attracted its first and only investment from Medtechnica, in the amount of $1M in 1996. In 2009 Flight Medical merged into a public shell company at a valuation of NIS 120 million, since then flight is traded on the Tel-Aviv Stock Exchange market.
Flight Medical is subsidiary of Medtechnica, and was sold on March 2011 as a part of the Medtechnica transaction.
C.D.P. develops software and computerized systems that enable the collection of medical data received from simulation equipment such as cameras, ultrasound and magnetic resonance imaging.
C.D.P. was founded, by Medtechnica, in 2000 with a single loan of $0.2M and was acquired in August 2010 by Philips Medical Systems for approximately $15M.
Pocared Diagnostics is a technology development company aims at provides an innovative solution for real-time, reagent-less In-Vitro Diagnostics (IVD) and offers a universal and robust system. Pocared's wide technological platform may be used to address a wide range of medical and industrial diagnostic applications. The company's first application will target medical IVD.
Since its inception, the Company raised over $50 million.
CureLight develops and markets therapeutic photo therapy solutions for the treatment of aesthetic and medical skin conditions. Its various Acne Therapy Systems incorporate narrow-spectrum, high-power, non-coherent computerized light systems, designed for effective and fast non-invasive medical treatments. Curelight systems utilize a full photo-monitoring method allowing online digital counting and graphing of the clinical progress.
CureLight was acquired in January 2008 after reaching insolvency. Following a quick and successful turnaround it was sold in October 2008 at 3X the original investment.
The Latest Updates